FrancophonIA/ELRC3.0 huggingface dataset:
English: • muscle aches and pains; back pain or bone pain
Danish: • muskelømhed og smerter, rygsmerter eller knoglesmerter
English: One vial of 10 ml of concentrate contains 3,95 g of ethanol anhydrous.
Danish: Hvert hætteglas med 10 ml koncentrat indeholder 3,95 g vandfri ethanol Alle hjælpestoffer er anført under pkt.
English: Oedema peripheral (G3/4: 0.2%)
Danish: Periferalt ødem (G3/4: 0,2%)
English: • blood clots.
Danish: • blodpropper
English: Docetaxel in combination with platinum agents in chemotherapy-naïve patients
Danish: Docetaxel i kombination med platinholdige stoffer hos patienter, der ikke tidligere er behandlet med kemoterapi
English: For patients with serum bilirubin levels > ULN and/or ALT and AST > 3.5 times the ULN concurrent with serum alkaline phosphatase levels > 6 times the ULN, no dose-reduction can be recommended and docetaxel should not be used unless strictly indicated.
Danish: Hos patienter med serumbilirubin > øvre normalværdi og/eller forhøjelse af ASAT/ALAT på > 3,5 gange øvre normalværdi og samtidig forhøjelse af basisk phosphatase på > 6 gange øvre normalværdi kan det ikke anbefales at reducere dosis.
English: NAME OF THE MEDICINAL PRODUCT Docetaxel Mylan 80 mg/4 ml concentrate for solution for infusion
Danish: LÆGEMIDLETS NAVN Docetaxel Mylan 80 mg/4 ml koncentrat til infusionsvæske, opløsning
English: Nausea (G3/4: 4%);
Danish: Kvalme (G3/4: 4%);
English: Lacrimation increased (G3/4: 0.6%)
Danish: Forhøjet lakrimation (G3/4: 0,6%)
English: Epistaxis (G3/4: 0%);
Danish: Vægtforøgelse (G3/4: 0%);
English: Dyspnoea (G3/4: 1%); Cough (G3/4: < 1%);
Danish: Dyspnø (G3/4: 1%); Hoste (G3/4: < 1%); Epistaxis (G3/4: < 1%)
English: Docetaxel was eliminated in both the urine and faeces following cytochrome P450-mediated oxidative metabolism of the tert-butyl ester group, within seven days, the urinary and faecal excretion accounted for about 6% and 75% of the administered radioactivity, respectively.
Danish: Inden for 7 dage udgjorde udskillelsen i urin og fæces henholdsvis ca. 6% og 75% af den indgivne radioaktivitet.
English: This medicinal product contains 50 vol % ethanol (alcohol), i.e. up to 1.58 g per vial, equivalent to 40 ml of beer or 17 ml wine per vial.
Danish: Dette lægemiddel indeholder 50 vol% ethanol (alkohol), dvs. op til 1,58 g pr. hætteglas svarende til 40 ml øl eller 17 ml vin pr. hætteglas.
English: NAME OF THE MEDICINAL PRODUCT Docetaxel Mylan 20 mg/1 ml concentrate for solution for infusion
Danish: LÆGEMIDLETS NAVN Docetaxel Mylan 20 mg/1 ml koncentrat til infusionsvæske, opløsning
English: Rash pruritus (G3/4: 0.7%); Nail disorders (G3/4: 0.7%); Skin exfoliation (G3/4: 0%)
Danish: Kløende udslæt (G3/4: 0,7%); Neglesygdomme (G3/4: 0,7%); Hudeksfoliering (G3/4: 0%)
English: One hundred eighty six patients were randomized to receive docetaxel (100 mg/m²) with or without trastuzumab; 60% of patients received prior anthracycline-based adjuvant chemotherapy.
Danish: 186 patienter blev randomiseret til docetaxel (100 mg/m²) med eller uden trastuzumab.
English: Docetaxel Mylan 200 mg/10 ml concentrate for solution for infusion Docetaxel
Danish: Docetaxel Mylan 200 mg/10 ml koncentrat til infusionsvæske, opløsning docetaxel
English: Between infusions of Docetaxel Mylan the following may occur, and the frequency may vary with the combinations of medicines that are received.
Danish: Følgende kan ske mellem Docetaxel Mylan-infusionerne.
English: Dehydration and pulmonary oedema have rarely been reported.
Danish: Der er rapporteret sjældne tilfælde af dehydrering og lungeødem.
English: Docetaxel Mylan monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy.
Danish: Docetaxel Mylan monoterapi er indiceret til behandling af patienter med lokalt fremskreden eller metastatisk brystcancer efter behandlingssvigt af kemoterapi.
English: Median survival (months) (95% CI)
Danish: Medianoverlevelse (måneder) (95% CI)
English: Stomatitis (G3/4: 18%); Diarrhoea (G3/4: 14%); Nausea (G3/4: 6%);
Danish: Diarre (G3/4: 4%); Kvalme (G3/4: 4%); Opkastning (G3/4: 3%)
English: Vomiting (G3/4: 7.6%); Diarrhoea (G3/4: 6.4%); Stomatitis (G3/4: 2%)
Danish: Diarré (G3/4: 6,4%); Stomatitis (G3/4: 2%)
English: Arrhythmia (G3/4: 1.0%)
Danish: Arytmi (G3/4: 1,0%)
English: Hearing impaired (G3/4: 0%)
Danish: Nedsat hørelse (G3/4: 0%)
English: Docetaxel Mylan 20 mg/1 ml concentrate for solution for infusion Docetaxel
Danish: Docetaxel Mylan 20 mg/1 ml koncentrat til infusionsvæske, opløsning docetaxel
English: One vial of 1 ml of concentrate contains 395 mg of ethanol anhydrous.
Danish: Hvert hætteglas med 1 ml koncentrat indeholder 395 mg vandfri ethanol Alle hjælpestoffer er anført under pkt.
English: Adjusted Hazard ratio (95% CI) *p-value
Danish: Justeret hazard ratio (95% CI) *p-værdi
English: Epistaxis (G3/4: < 1%)
Danish: Erythematøst udslæt (G3/4: < 1%);
English: Docetaxel Mylan 80 mg/4 ml concentrate for solution for infusion Docetaxel
Danish: Docetaxel Mylan 80 mg/4 ml koncentrat til infusionsvæske, opløsning docetaxel
English: Cough (G3/4: 0%)
Danish: Hoste (G3/4: 0%)
English: Undesirable effects on the testis observed in rodent toxicity studies suggest that docetaxel may impair male fertility
Danish: Toksicitetsstudier hos gnavere har vist uønskede påvirkninger af testisfunktionen.
English: Asthenia (G3/4: 10.0%); Pyrexia (G3/4: NA);
Danish: Asteni (G3/4: 10,0%); Feber (G3/4: NA);
English: Vomiting (G3/4: 3%)
Danish: Opkastning (G3/4: 3%)
English: Dyspnoea (G3/4: 0.6%); Cough (G3/4: 0%)
Danish: Epistaxis (G3/4: 0%); Dyspnø (G3/4: 0,6%); Hoste (G3/4: 0%)
English: For patients who are dosed initially at docetaxel 75 mg/m² in combination with cisplatin and whose nadir of platelet count during the previous course of therapy is < 25,000 cells/mm3, or in patients who experience febrile neutropenia, or in patients with serious non-haematologic toxicities, the docetaxel dose in subsequent cycles should be reduced to 65 mg/m².
Danish: I de følgende tilfælde bør docetaxel-dosis reduceres til 65 mg/m² i efterfølgende behandlingsrunder: 1) hos patienter med en initialdosis på 75 mg/m² docetaxel i kombination med cisplatin, med en minimum blodpladeværdi under den tidligere behandlingsrunde på < 25.000 celler/mm
English: Tabulated list of adverse reactions in non-small cell lung cancer for Docetaxel 75 mg/m² single agent MedDRA system organ classes
Danish: Tabel over bivirkninger ved behandling af ikke-småcellet lungekræft med Docetaxel 75 mg/m² enkeltstof
English: This medicinal product contains 50 vol % ethanol (alcohol), i.e. up to 0.395 g per vial, equivalent to 10 ml of beer or 4 ml wine per vial.
Danish: Dette lægemiddel indeholder 50 vol% ethanol (alkohol), dvs. op til 0,395 g pr. hætteglas svarende til 10 ml øl eller 4 ml vin pr. hætteglas.
English: Hearing impaired (G3/4: 1.2%)
Danish: Ødem (G3/4: 1,2%)
English: This medicinal product contains 50 vol % ethanol (alcohol), i.e. up to 3.95 g per vial, equivalent to 100 ml of beer or 40 ml wine per vial.
Danish: Dette lægemiddel indeholder 50 vol% ethanol (alkohol), dvs. op til 3,95 g pr. hætteglas svarende til 100 ml øl eller 40 ml vin pr. hætteglas.
English: Gastrointestinal haemorrhage (G3/4:
Danish: Gastrointestinal hæmoragi (G3/4: 0,6%)
English: No of positive nodes Overall
Danish: Antal positive lymfeknuder Total
English: Onycholysis (G3/4: 1%)
Danish: Misfarvning af negle; Onycholysis (G3/4: 1%)
English: Lymphoedema (G3/4: 0%)
Danish: Flebitis (G3/4: 0%)
English: Exfoliative rash (G3/4: 0.3%)
Danish: Exfoliativt udslæt (G3/4: 0,3%)
English: Vomiting (G3/4: 0.6%)
Danish: Cancersmerter (G3/4: 0,6%)
English: This medicine contains 50 vol % ethanol (alcohol), i.e. up to 0.395 g per vial equivalent to 10 ml of beer or 4 ml wine per vial.
Danish: Denne medicin indeholder 50 vol% ethanol (alkohol), dvs. maksimalt 0,395 g pr. hætteglas svarende til 10 ml øl eller 4 ml vin pr. hætteglas.
English: Skin exfoliative (G3/4: 0.6%)
Danish: Hudeksfoliering (G3/4: 0,6%)
English: For breast and non-small cell lung cancers, premedication consisting of an oral corticosteroid, such as dexamethasone 16 mg per day (e.g. 8 mg BID) for 3 days starting 1 day prior to docetaxel administration, unless contraindicated, can reduce the incidence and severity of fluid retention as well as the severity of hypersensitivity reactions.
Danish: Medmindre det er kontraindiceret, kan der til brystcancer og ikke-småcellet lungecancer gives et oralt kortikosteroid som præmedicinering, eksempelvis dexamethason 16 mg pr dag i 3 dage (f.eks. 8 mg 2 gange dagligt).
English: Pain in extremity (G3/4: < 1%); Back pain (G3/4: 1%)
Danish: Smerter i ekstremiteterne (G3/4: < 1%);
English: (G3/4: 1.2%)
Danish: Feber (G3/4: 1,2%)
English: Dysgeusia/Parosmia (G3/4: 0.4%);
Danish: Kløende udslæt (G3/4: 0,7%);
English: Hazard ratio (95% CI) *p-value
Danish: Hazard ratio (95% CI) *p-værdi
English: Hazard ratio: (95% CI) **p-value
Danish: Hazard ratio: (95% CI) **p-værdi
English: Tell them immediately if you notice any of these effects.
Danish: Hvis du får nogle af disse bivirkninger, så fortæl det straks til hospitalspersonalet.
English: Diarrhoea (G3/4: 19.7%); Nausea (G3/4: 16%);
Danish: Kvalme (G3/4: 9,6%); Opkastning (G3/4: 7,6%);
English: Nausea (G3/4: 5%); Stomatitis (G3/4: 7.8%);
Danish: Stomatitis (G3/4: 7,8%);
English: Anaemia (G3/4: 3%); Neutropenia (G3/4:
Danish: Blod og lymfesystem Anæmi (G3/4: 3%); Neutropeni (G3/4: 59,2%);
English: Arrhythmia (G3/4: 0.2%)
Danish: Mavesmerter (G3/4: 0,4%)
English: Venous disorder (G3/4: 0.6%)
Danish: Venøs lidelse (G3/4: 0,6%)
English: Single-use vial.
Danish: Hætteglas til engangsbrug.
English: The following information is intended for healthcare professionals only: PREPARATION GUIDE FOR USE WITH DOCETAXEL MYLAN CONCENTRATE FOR SOLUTION FOR INFUSION
Danish: FREMSTILLINGSVEJLEDNING FOR DOCETAXEL MYLAN KONCENTRAT TIL INFUSIONSVÆSKE, OPLØSNING
English: Arrhythmia (G3/4: 0.7%)
Danish: Arytmi (G3/4: 0,7%)
English: Pharmaceutical form
Danish: Lægemidde l-form
English: The European Commission granted a marketing authorisation valid throughout the European Union for Protaphane on 7 October 2002.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Protaphane den 7. oktober 2002.
English: This is a summary of the European public assessment report (EPAR) for Protaphane.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Protaphane.
English: Other information about Protaphane
Danish: Andre oplysninger om Protaphane
English: A risk management plan has been developed to ensure that Protaphane is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Protaphane anvendes så sikkert som muligt.
English: The full EPAR for Protaphane is available ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Protaphane findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Protaphane.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Protaphane.
English: What measures are being taken to ensure the safe and effective use of Protaphane?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Protaphane?
English: For more information about treatment with Protaphane, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Protaphane, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: What is the risk associated with Protaphane?
Danish: Hvilken risiko er der forbundet med Protaphane?
English: This gives Protaphane a longer duration of action.
Danish: Det giver Protaphane en længerevarende virkning.
English: Protaphane has been studied in four main clinical trials, which included a total of 557 patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 81 patients), or type 2 diabetes, when the body is unable to use insulin effectively (two studies involving 476 patients).
Danish: Protaphane blev undersøgt i fire kliniske hovedundersøgelser med i alt 557 patienter med type 1diabetes, hvor bugspytkirtlen ikke kan producere insulin (to undersøgelser, som omfattede 81 patienter), eller type 2-diabetes, hvor kroppen ikke er i stand til at udnytte insulin effektivt (to undersøgelser, som omfattede 476 patienter).
English: The active substance in Protaphane, human insulin, is produced by a method known as ‘recombinant technology': it is made by yeast cells into which a gene (DNA) has been introduced which makes them able to produce insulin.
Danish: Det aktive stof i Protaphane, human insulin, produceres via en metode, der er kendt som "rekombinant teknologi": Det fremstilles af gærceller, der har fået indsat et gen (DNA), som gør dem i stand til at producere insulin.
English: The CHMP decided that Protaphane's benefits are greater than its risks and recommended that it be given marketing authorisation.
Danish: CHMP besluttede, at fordelene ved Protaphane opvejer risiciene, og anbefalede udstedelse af en markedsføringstilladelse for Protaphane.
English: The most common side effect with Protaphane (seen in more than 1 patient in 10) is hypoglycaemia (low blood glucose levels).
Danish: Den hyppigste bivirkning ved Protaphane (som optræder hos flere end 1 ud af 10 patienter) er hypoglykæmi (lave blodsukkerniveauer).
English: Protaphane was effective for both type 1 and type 2 diabetes, and when using a standard injection or one of the pre-filled pens.
Danish: Protaphane var effektivt ved såvel type 1- som type 2-diabetes og ved anvendelsen af en standardinjektion eller en af de fyldte penne.
English: Protaphane led to a decrease in the level of HbA1c, indicating that blood sugar levels had been controlled to a similar level to that seen with other human insulin.
Danish: Protaphane medførte et fald i HbA1c-niveauet, hvilket tyder på, at blodsukkeret var blevet holdt under kontrol på et niveau svarende til det, der var observeret for andre typer human insulin.
English: In most patients, Protaphane was compared with other types of human insulin or insulin analogues.
Danish: Hos størstedelen af patienterne blev Protaphane sammenlignet med andre typer human insulin eller insulinanaloger.
English: Why has Protaphane been approved?
Danish: Hvorfor blev Protaphane godkendt?
English: Protaphane contains insulin mixed with another substance, protamine, in an ‘isophane' form which is absorbed much more slowly during the day.
Danish: Protaphane indeholder insulin blandet med et andet stof, protamin, i en form, der kaldes "isofan", som optages langsommere dagen igennem.
English: Protaphane is a long-acting insulin.
Danish: Protaphane er et langtidsvirkende insulin.
English: Further studies were also carried out in 225 patients comparing injecting Protaphane using a syringe, or using a pre-filled pen (InnoLet or FlexPen).
Danish: Der blev også gennemført yderligere undersøgelser af 225 patienter, hvor man sammenlignede injektion af Protaphane med kanyle eller med brug af en fyldt pen (InnoLet eller FlexPen).
English: Protaphane is used to treat diabetes.
Danish: Protaphane anvendes til behandling af diabetes (sukkersyge).
English: Protaphane is given by injection under the skin, usually in the thigh, the abdominal wall (at the front of the waist), the gluteal region (buttocks) or the deltoid region (shoulder).
Danish: Protaphane gives som injektion under huden, sædvanligvis i låret, bugvæggen (maveskindet), sædemuskelregionen (ballerne) eller deltamuskelregionen (skulderen).
English: Protaphane is a suspension for injection that contains the active substance human insulin.
Danish: Protaphane er en injektionsvæske, suspension, som indeholder det aktive stof human insulin.
English: The studies measured the level of fasting blood glucose or glycosylated haemoglobin (HbA1c, the haemoglobin in the blood that has glucose attached).
Danish: I undersøgelserne målte man blodsukkeret i fastende tilstand eller mængden af glykosyleret hæmoglobin (HbA1c, et hæmoglobin, som binder glukose til sig).
English: What benefit has Protaphane shown during the studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Protaphane?
English: How has Protaphane been studied?
Danish: Hvordan blev Protaphane undersøgt?
English: Protaphane is a replacement insulin which is very similar to the insulin made by the pancreas.
Danish: Protaphane er et erstatningsinsulin, der næsten er identisk med det insulin, som produceres af bugspytkirtlen.
English: What is Protaphane?
Danish: Hvad er Protaphane?
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Protaphane, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: Protaphane, herunder passende forholdsregler, som patienter og sundhedspersonale skal følge.
English: What is Protaphane used for?
Danish: Hvad anvendes Protaphane til?
English: How is Protaphane used?
Danish: Hvordan anvendes Protaphane?
English: How does Protaphane work?
Danish: Hvordan virker Protaphane?
English: MA (EU) number
Danish: MT (EU)-nummer (Særnavn) Navn
English: Bristol-Myers Squibb GesmbH Rivergate / Gate 1 / 5.OG, Handelskai 92, 1200 Vienna, Austria
Danish: Bristol-Myers Squibb GesmbH Rivergate / Gate 1 / 5.OG, Handelskai 92, 1200 Wien, Østrig
English: Budějovická 778/3, Michle 140 00 Prague 4, Czech Republic
Danish: Budějovická 778/3, Michle 140 00 Prague 4, Tjekkiet
English: Orteliuslaan 1000, 3528 BD Utrecht, The Netherlands
Danish: Orteliuslaan 1000, 3528 BD Utrecht, Holland
English: Orteliuslaan 1000, Utrecht, 3528 BD, The Netherlands
Danish: Orteliuslaan 1000, Utrecht, 3528 BD, Holland
English: Budějovická 778/3, Michle, 140 00 Prague, Czech Republic
Danish: Budějovická 778/3, Michle, 140 00 Prag, Tjekkiet
English: 300 MBq/ml Solution for injection
Danish: 300 MBq/ml Injektionsvæske, opløsning
English: 1 vial
Danish: 1 ampul
English: MA (EU) Number (Invented) name
Danish: MF (EU)-nummer (Særnavn)
English: If you take SOMAC Control for longer periods, this may cause additional risks, such as:
Danish: Hvis du tager SOMAC Control i længere perioder, kan det medføre yderligere risici i form af:
English: The following additional risks are considered relevant for long-term use
Danish: Nedenstående yderligere risici anses for relevante i forbindelse med langvarig anvendelse:
English: SOMAC Control may stop certain other medicines from working properly.
Danish: SOMAC Control kan medføre, at andre lægemidler ikke virker ordentligt.
English: SOMAC Control 20 mg gastro-resistant tablets should not be chewed or crushed, and should be swallowed whole with liquid before a meal.
Danish: SOMAC Control 20 mg enterotabletter bør ikke tygges eller knuses, men skal sluges hele med væske før et måltid.
English: SOMAC Control has no or negligible influence on the ability to drive and use machines.
Danish: SOMAC Control påvirker ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj og betjene maskiner.
English: To avoid this interference, SOMAC Control treatment should be stopped for at least 5 days before CgA measurements (see section 5.1).
Danish: For at undgå denne interferens bør SOMAC Control seponeres mindst 5 dage inden måling af CgA (se pkt.
English: - methotrexate (used to treat rheumatoid arthritis, psoriasis, and cancer) - if you are taking methotrexate your doctor may temporarily stop your SOMAC Control treatment because pantoprazole can increase levels of methotrexate in the blood.
Danish: - methotrexat (bruges til behandling af reumatoid artrit, psoriasis og cancer) - hvis du tager methotrexat, kan din læge midlertidigt stoppe din behandling med SOMAC Control, da SOMAC Control kan forøge niveauet af methotrexat i blodet.
English: This leaflet was last revised in {mm/yyyy}
Danish: Denne indlægsseddel blev senest ændret {MM/ÅÅÅÅ}
English: Stop taking SOMAC Control when you are completely symptom-free.
Danish: Stop med at tage SOMAC Control, når du er symptomfri.
English: SOMAC Control should not be used by children and adolescents under 18 years of age due to a lack of safety information in this younger age group.
Danish: SOMAC Control må ikke bruges af børn og unge under 18 år pga. manglende dokumentation for sikkerhed i denne aldersgruppe.
English: SOMAC Control is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy.
Danish: SOMAC Control bør ikke anvendes til børn og unge under 18 år på grund af utilstrækkelige data vedrørende sikkerhed og virkning.
English: SOMAC Control is available in Alu/Alu blisters with or without cardboard reinforcement.
Danish: SOMAC Control findes i aluminim/aluminium-blister med eller uden kartonforstærkning.
English: If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping SOMAC Control.
Danish: Hvis sådanne hudreaktioner optræder, navnlig på hudområder udsat for sollys, og er ledsaget af arthralgi, bør patienten straks søge læge, og lægen bør overveje at seponere SOMAC Control.
English: Liver enzymes increased (transaminases , γ-GT)
Danish: Forhøjede leverenzymer (transaminaser , γ-GT)
English: SOMAC Control contains the active substance pantoprazole, which blocks the ‘pump' that produces stomach acid.
Danish: SOMAC Control indeholder det aktive stof pantoprazol, som blokerer den ”pumpe”, der producerer mavesyre.
English: You may experience relief from your acid reflux and heartburn symptoms after just one day of treatment with SOMAC Control, but this medicine is not meant to bring immediate relief.
Danish: Du kan opleve lindring af dine symptomer på sure opstød og halsbrand efter kun en dags behandling med SOMAC Control, men denne medicin har ikke til hensigt at give øjeblikkelig lindring.
English: Do not take SOMAC Control with other medicines which limit the amount of acid produced in your stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an H2 antagonist (e.g. ranitidine, famotidine).
Danish: Tag ikke SOMAC Control samtidigt med anden medicin, som begrænser mængden af syre i din mave, så som andre syrepumpehæmmere (omeprazol, lansoprazol eller rabeprazol) eller en H2-antagonist (f.eks. ranitidin, famotidin).
English: You must not use SOMAC Control if you are taking HIV protease inhibitors.
Danish: Du må ikke tage SOMAC Control, hvis du tager HIV-proteasehæmmere.
English: However, you may take SOMAC Control with antacids (e.g. magaldrate, alginic acid, sodium bicarbonate, aluminium hydroxide, magnesium carbonate, or combinations thereof), if needed.
Danish: Du må gerne tage SOMAC Control samtidig med syreneutraliserende medicin (f.eks. magaldrat, alginsyre, natriumbicarbonat, aluminiumhydroxid, magnesiumcarbonat eller kombinationer heraf), hvis det er nødvendigt.
English: SOMAC Control may reduce the absorption of active substances whose bioavailability is dependent on the gastric pH (e.g. ketoconazole).
Danish: SOMAC Control kan reducere absorptionen af aktive stoffer, hvis biotilgængelighed er pH-afhængig (fx. ketoconazol).
English: What SOMAC Control contains - The active substance is pantoprazole.
Danish: SOMAC Control indeholder: - Aktivt stof: Pantoprazol.
English: If you forget to take SOMAC Control
Danish: Hvis du har glemt at tage SOMAC Control
English: SOMAC Control should not be used during breast-feeding.
Danish: SOMAC Control bør ikke anvendes under graviditet.